Unity Biotechnology Inc. (UBX) NASDAQ
$1.50 (0.03) (-1.96%)
Market Cap: $25.69M
As of 05/16/24 11:30 AM EDT. Market open.
Unity Biotechnology Inc. (UBX)
NASDAQ
$1.50
(0.03) (-1.96%)
Market Cap: $25.69M
As of 05/16/24 11:30 AM EDT. Market open.
Add to Portfolio
unity biotechnology is developing therapeutics to extend healthspan by slowing, halting or reversing diseases of aging. unity's initial focus is on creating senolytic medicines to selectively eliminate senescent cells and thereby treat age-related diseases, such as osteoarthritis, eye diseases and pulmonary diseases. more information is available at ... read more
COMPANY PROFILE
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
CEO
Anirvan Ghosh
Full Time Employees
46
CEO Compensation (Base)
$500,000
CEO Compensation (Total)
$2.73M
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
CEO
Anirvan Ghosh
Full Time Employees
46
CEO Compensation (Base)
$500,000
CEO Compensation (Total)
$2.73M
Address
3280 Bayshore Blvd, California, Brisbane, 94005-1028.
PRICE CHART FOR UNITY BIOTECHNOLOGY INC
From:
To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$1.51
Previous Close
$1.53
Days Range
$1.52 - $1.60
52 week range
$1.46 - $3.82
Volume
79,922
Avg. Volume (30 days)
42,913
Market Cap
$25.69M
Dividend Yield
-
P/E
-
Shares Outstanding
16,789,577
Open
$1.51
Previous Close
$1.53
Days Range
$1.52 - $1.60
52 week range
$1.46 - $3.82
Volume
79,922
Avg. Volume (30 days)
42,913
Market Cap
$25.69M
Dividend Yield
-
P/E
-
Shares Outstanding
16,789,577
FINANCIAL STATEMENTS FOR UNITY BIOTECHNOLOGY INC
LOADING...
INSIDER TRANSACTIONS FOR UNITY BIOTECHNOLOGY INC
Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
Ghosh Anirvan | Chief Executive Officer | May 02, 2024 | Sale | $1.55 | 603 | 935 | 78,143 | May 03, 2024, 04:05 PM |
Ghosh Anirvan | Chief Executive Officer | Feb 02, 2024 | Sale | $1.71 | 680 | 1,163 | 78,746 | Feb 05, 2024, 04:05 PM |
Ghosh Anirvan | Chief Executive Officer | Jan 30, 2024 | Sale | $1.71 | 1,183 | 2,023 | 79,426 | Jan 31, 2024, 04:05 PM |
Ghosh Anirvan | Chief Executive Officer | Nov 02, 2023 | Sale | $1.83 | 589 | 1,078 | 80,609 | Nov 03, 2023, 04:05 PM |
Ghosh Anirvan | Chief Executive Officer | Oct 30, 2023 | Sale | $1.90 | 1,024 | 1,946 | 81,198 | Oct 31, 2023, 04:05 PM |
Ghosh Anirvan | Chief Executive Officer | Sep 14, 2023 | Sale | $2.47 | 1,246 | 3,078 | 82,222 | Sep 15, 2023, 04:08 PM |
Ghosh Anirvan | Chief Executive Officer | Aug 02, 2023 | Sale | $2.94 | 581 | 1,708 | 83,468 | Aug 03, 2023, 04:13 PM |
Ghosh Anirvan | Chief Executive Officer | Jul 31, 2023 | Sale | $2.86 | 1,020 | 2,917 | 84,049 | Aug 01, 2023, 04:05 PM |
Ghosh Anirvan | Chief Executive Officer | Jun 26, 2023 | Sale | $3.20 | 1,177 | 3,766 | 85,069 | Jun 27, 2023, 05:10 PM |
Ghosh Anirvan | Chief Executive Officer | Jun 14, 2023 | Sale | $3.39 | 1,212 | 4,109 | 86,246 | Jun 15, 2023, 05:58 PM |
Ghosh Anirvan | Chief Executive Officer | May 02, 2023 | Sale | $2.17 | 588 | 1,276 | 87,458 | May 03, 2023, 05:26 PM |
Ghosh Anirvan | Chief Executive Officer | May 01, 2023 | Sale | $2.15 | 1,020 | 2,193 | 88 | May 02, 2023, 04:32 PM |
Ghosh Anirvan | Chief Executive Officer | Mar 31, 2023 | Sale | $1.70 | 1,959 | 3,330 | 89,066 | Apr 03, 2023, 04:55 PM |
Dananberg Jamie | Chief Medical Officer | Mar 31, 2023 | Sale | $1.70 | 420 | 714 | 62,817 | Apr 03, 2023, 04:51 PM |
Dananberg Jamie | Chief Medical Officer | Mar 14, 2023 | Sale | $4.00 | 1,005 | 4,020 | 63,237 | Mar 15, 2023, 05:02 PM |
Ghosh Anirvan | Chief Executive Officer | Mar 14, 2023 | Sale | $4.00 | 1,210 | 4,840 | 91,025 | Mar 15, 2023, 04:51 PM |
Dananberg Jamie | Chief Medical Officer | Feb 02, 2023 | Sale | $4.84 | 863 | 4,177 | 64,242 | Feb 03, 2023, 04:33 PM |
Ghosh Anirvan | Chief Executive Officer | Feb 02, 2023 | Sale | $4.84 | 2,573 | 12,453 | 92,235 | Feb 03, 2023, 04:27 PM |
Ghosh Anirvan | Chief Executive Officer | Jan 30, 2023 | Sale | $4.45 | 1,140 | 5,073 | 94,808 | Jan 31, 2023, 04:48 PM |
Ghosh Anirvan | Chief Executive Officer | Dec 14, 2022 | Sale | $2.85 | 1,274 | 3,631 | 95,948 | Dec 15, 2022, 04:48 PM |
Dananberg Jamie | Chief Medical Officer | Dec 14, 2022 | Sale | $2.85 | 1,016 | 2,896 | 65,105 | Dec 15, 2022, 04:44 PM |
Sullivan Lynne Marie | CFO & Head of Corp. Dev. | May 15, 2022 | Option Exercise | $6.89 | 925 | 6,373 | 33,009 | Nov 21, 2022, 05:26 PM |
Ghosh Anirvan | Chief Executive Officer | Nov 03, 2022 | Sale | $2.40 | 1,099 | 2,638 | 97,222 | Nov 04, 2022, 04:49 PM |
Ghosh Anirvan | Chief Executive Officer | Sep 14, 2022 | Sale | $0.48 | 13,706 | 6,579 | 983,210 | Sep 15, 2022, 04:11 PM |
Dananberg Jamie | Chief Medical Officer | Sep 14, 2022 | Sale | $0.48 | 10,923 | 5,243 | 661,213 | Sep 15, 2022, 04:10 PM |
Ghosh Anirvan | Chief Executive Officer | Aug 01, 2022 | Sale | $0.67 | 10,446 | 6,999 | 996,916 | Aug 02, 2022, 04:12 PM |
Dananberg Jamie | Chief Medical Officer | Jun 27, 2022 | Sale | $0.59 | 4,398 | 2,595 | 672,136 | Jun 28, 2022, 06:11 PM |
Ghosh Anirvan | Chief Executive Officer | Jun 27, 2022 | Sale | $0.59 | 12,149 | 7,168 | 1,007,362 | Jun 28, 2022, 06:07 PM |
Dananberg Jamie | Chief Medical Officer | Jun 21, 2022 | Sale | $0.62 | 3,697 | 2,292 | 676,534 | Jun 22, 2022, 04:49 PM |
Ghosh Anirvan | Chief Executive Officer | Jun 14, 2022 | Option Exercise | $0.63 | 12,683 | 7,990 | 1,019,511 | Jun 15, 2022, 04:36 PM |
Dananberg Jamie | Chief Medical Officer | Jun 14, 2022 | Option Exercise | $0.63 | 10,530 | 6,634 | 680,231 | Jun 15, 2022, 04:34 PM |
Ghosh Anirvan | Chief Executive Officer | May 02, 2022 | Option Exercise | $0.88 | 7,729 | 6,802 | 1,032,194 | May 03, 2022, 05:18 PM |
Ghosh Anirvan | Chief Executive Officer | Mar 31, 2022 | Option Exercise | $1.14 | 14,472 | 16,498 | 1,039,923 | Apr 01, 2022, 04:24 PM |
Dananberg Jamie | Chief Medical Officer | Mar 31, 2022 | Option Exercise | $1.14 | 4,188 | 4,774 | 690,761 | Apr 01, 2022, 04:24 PM |
Ghosh Anirvan | Chief Executive Officer | Mar 14, 2022 | Option Exercise | $0.88 | 9,272 | 8,159 | 1,054,395 | Mar 15, 2022, 04:54 PM |
Dananberg Jamie | Chief Medical Officer | Mar 14, 2022 | Option Exercise | $0.88 | 10,581 | 9,311 | 694,949 | Mar 15, 2022, 04:53 PM |
Dananberg Jamie | Chief Medical Officer | Dec 14, 2021 | Option Exercise | $1.63 | 10,614 | 17,301 | 659,697 | Dec 15, 2021, 04:26 PM |
Dananberg Jamie | Chief Medical Officer | Mar 30, 2021 | Option Exercise | $2.95 | 40,564 | 119,664 | 670,311 | Oct 01, 2021, 09:57 PM |
Dananberg Jamie | Chief Medical Officer | Jun 21, 2021 | Option Exercise | $4.18 | 3,515 | 14,693 | 685,875 | Jun 23, 2021, 05:03 PM |
Dananberg Jamie | Chief Medical Officer | Mar 30, 2021 | Option Exercise | $5.73 | 2,829 | 16,210 | 689,390 | Apr 01, 2021, 05:13 PM |
David Nathaniel E | President | Dec 16, 2020 | Sale | $5.24 | 1,700,000 | 8,908,000 | 624,703 | Dec 18, 2020, 05:14 PM |
Goeltz II Robert C. | Chief Financial Officer | Jun 22, 2020 | Option Exercise | $9.67 | 2,483 | 24,011 | 161,027 | Jun 24, 2020, 05:03 PM |
David Nathaniel E | President | Jun 22, 2020 | Option Exercise | $9.67 | 2,483 | 24,011 | 2,324,703 | Jun 24, 2020, 05:00 PM |
Marquess Dan | Chief Scientific Officer | Jun 22, 2020 | Option Exercise | $9.67 | 2,483 | 24,011 | 380,690 | Jun 24, 2020, 04:59 PM |
Dananberg Jamie | Chief Medical Officer | Jun 22, 2020 | Option Exercise | $9.67 | 2,483 | 24,011 | 452,219 | Jun 24, 2020, 04:59 PM |
Tompkins Tamara | See Remarks | Jun 22, 2020 | Option Exercise | $9.67 | 2,483 | 24,011 | 42,847 | Jun 24, 2020, 04:58 PM |
Leonard Keith R | Director | Jun 22, 2020 | Option Exercise | $9.67 | 4,711 | 45,555 | 89,546 | Jun 24, 2020, 04:58 PM |
David Nathaniel E | President | Jun 05, 2020 | Buy | $8.90 | 3,200 | 28,478 | 2,327,186 | Jun 09, 2020, 04:44 PM |
Goeltz II Robert C. | Chief Financial Officer | Feb 24, 2020 | Option Exercise | $3.43 | 10,000 | 34,300 | 134,404 | Feb 26, 2020, 05:48 PM |
Leonard Keith R | Chief Executive Officer | Jun 19, 2019 | Option Exercise | $3.40 | 20,000 | 68,000 | 170,782 | Jun 19, 2019, 09:14 PM |
Goeltz II Robert C. | Chief Financial Officer | Oct 10, 2018 | Option Exercise | $3.43 | 5,000 | 17,150 | 101,348 | Oct 12, 2018, 05:36 PM |
Load More Insider Transactions
Buy
Sale
Option Exercise
Owner | Relationship | Date | Value($) |
Ghosh Anirvan | Chief Executive Officer | 05/02/2024 | 935 |
Ghosh Anirvan | Chief Executive Officer | 02/02/2024 | 1,163 |
Ghosh Anirvan | Chief Executive Officer | 01/30/2024 | 2,023 |
Ghosh Anirvan | Chief Executive Officer | 11/02/2023 | 1,078 |
Ghosh Anirvan | Chief Executive Officer | 10/30/2023 | 1,946 |
Ghosh Anirvan | Chief Executive Officer | 09/14/2023 | 3,078 |
Ghosh Anirvan | Chief Executive Officer | 08/02/2023 | 1,708 |
Ghosh Anirvan | Chief Executive Officer | 07/31/2023 | 2,917 |
Ghosh Anirvan | Chief Executive Officer | 06/26/2023 | 3,766 |
Ghosh Anirvan | Chief Executive Officer | 06/14/2023 | 4,109 |
Ghosh Anirvan | Chief Executive Officer | 05/02/2023 | 1,276 |
Ghosh Anirvan | Chief Executive Officer | 05/01/2023 | 2,193 |
Ghosh Anirvan | Chief Executive Officer | 03/31/2023 | 3,330 |
Dananberg Jamie | Chief Medical Officer | 03/31/2023 | 714 |
Dananberg Jamie | Chief Medical Officer | 03/14/2023 | 4,020 |
Ghosh Anirvan | Chief Executive Officer | 03/14/2023 | 4,840 |
Dananberg Jamie | Chief Medical Officer | 02/02/2023 | 4,177 |
Ghosh Anirvan | Chief Executive Officer | 02/02/2023 | 12,453 |
Ghosh Anirvan | Chief Executive Officer | 01/30/2023 | 5,073 |
Ghosh Anirvan | Chief Executive Officer | 12/14/2022 | 3,631 |
Dananberg Jamie | Chief Medical Officer | 12/14/2022 | 2,896 |
Sullivan Lynne Marie | CFO & Head of Corp. Dev. | 05/15/2022 | 6,373 |
Ghosh Anirvan | Chief Executive Officer | 11/03/2022 | 2,638 |
Ghosh Anirvan | Chief Executive Officer | 09/14/2022 | 6,579 |
Dananberg Jamie | Chief Medical Officer | 09/14/2022 | 5,243 |
Ghosh Anirvan | Chief Executive Officer | 08/01/2022 | 6,999 |
Dananberg Jamie | Chief Medical Officer | 06/27/2022 | 2,595 |
Ghosh Anirvan | Chief Executive Officer | 06/27/2022 | 7,168 |
Dananberg Jamie | Chief Medical Officer | 06/21/2022 | 2,292 |
Ghosh Anirvan | Chief Executive Officer | 06/14/2022 | 7,990 |
Dananberg Jamie | Chief Medical Officer | 06/14/2022 | 6,634 |
Ghosh Anirvan | Chief Executive Officer | 05/02/2022 | 6,802 |
Ghosh Anirvan | Chief Executive Officer | 03/31/2022 | 16,498 |
Dananberg Jamie | Chief Medical Officer | 03/31/2022 | 4,774 |
Ghosh Anirvan | Chief Executive Officer | 03/14/2022 | 8,159 |
Dananberg Jamie | Chief Medical Officer | 03/14/2022 | 9,311 |
Dananberg Jamie | Chief Medical Officer | 12/14/2021 | 17,301 |
Dananberg Jamie | Chief Medical Officer | 03/30/2021 | 119,664 |
Dananberg Jamie | Chief Medical Officer | 06/21/2021 | 14,693 |
Dananberg Jamie | Chief Medical Officer | 03/30/2021 | 16,210 |
David Nathaniel E | President | 12/16/2020 | 8,908,000 |
Goeltz II Robert C. | Chief Financial Officer | 06/22/2020 | 24,011 |
David Nathaniel E | President | 06/22/2020 | 24,011 |
Marquess Dan | Chief Scientific Officer | 06/22/2020 | 24,011 |
Dananberg Jamie | Chief Medical Officer | 06/22/2020 | 24,011 |
Tompkins Tamara | See Remarks | 06/22/2020 | 24,011 |
Leonard Keith R | Director | 06/22/2020 | 45,555 |
David Nathaniel E | President | 06/05/2020 | 28,478 |
Goeltz II Robert C. | Chief Financial Officer | 02/24/2020 | 34,300 |
Leonard Keith R | Chief Executive Officer | 06/19/2019 | 68,000 |
Goeltz II Robert C. | Chief Financial Officer | 10/10/2018 | 17,150 |
Load More Insider Transactions
FUNDS WITH A POSITION IN UNITY BIOTECHNOLOGY INC
Fund | # Shares Owned | % of Portfolio | % Change | Investing Style |
---|---|---|---|---|
GEODE CAPITAL MANAGEMENT, LLC | 134,133 | 0.00002% | 1.78% | Other |
BLACKROCK INC. | 112,329 | 0% | -0.67% | Other |
RENAISSANCE TECHNOLOGIES LLC | 106,941 | 0.00028% | 180.16% | Other |
OCONNOR, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS (LLC) | 70,397 | 0.00826% | -24.06% | Value |
CHANGE IN SHARES OUTSTANDING FOR UNITY BIOTECHNOLOGY INC
STOCK BUYBACKS FOR UNITY BIOTECHNOLOGY INC
Load More
Period of Report: 03/31/2024
10-K/10-Q Filings: View
Previous Period
% Change in Shares
Quarter
12/31/2023
6.54%
1Q
09/30/2023
14.98%
2Q
06/30/2023
16.35%
3Q
03/31/2023
17.27%
4Q
12/31/2022
76.79%
5Q
09/30/2022
66.65%
6Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR UNITY BIOTECHNOLOGY INC
LOADING...